Vaccinating babies in Nigeria |
|
Working with the U.S. Centers for Diseases Control and Prevention (CDC), Global Immunization Division, and the African Field Epidemiology Network (AFENET) one of our team, Dr. Catherine Freeland has gone to Nigeria and collaborated with local health care providers to increase birth-dose vaccinations.
Their first research publication appeared last month in a scholarly journal.
"Barriers and facilitators to hepatitis B birth dose vaccination: Perspectives from healthcare providers and pregnant women accessing antenatal care in Nigeria" is posted here.
|
|
|
Just in time for Father's Day, #justB: DeWayne's story |
DeWayne contracted hepatitis B when he had a blood transfusion as a child. Growing up in foster care and not having health insurance, he went without treatment for most of his life.
After getting married and becoming a dad, however, DeWayne was motivated to take control of his health. He started seeing a doctor, taking medication to control his hepatitis B and living a healthier lifestyle.
Please see his story here.
|
|
Everyone can participate in a "research showcase" online |
Submissions for the Second Annual HepBcommunity.org Research Showcase are now being accepted! Hep B researchers in basic, translational, clinical, public health or social science are invited to showcase their research to encourage dialogue between the scientific and affected communities. There are monetary prizes for researchers with the most engaging discussions!
Forum members will have a chance to ask questions and cast votes for the top research and forum members will have a chance to win monetary prizes for posting the best questions! Research threads must be posted by June 20 and voting closes July 18. For details on how you can participate, please visit the HepBCommunity now.
|
|
NEW FAQs: new questions that we hear from
people living with hep B on a regular basis
|
The Hep B Foundation Frequently Asked Questions page is a wonderful resource for anyone with questions about hepatitis B. The questions are written based on real consults that we receive regularly.
We just updated two FAQs:
- If the currently approved hepatitis B drugs do not provide a cure, then how are they helping?
- Is there any special diet for people living with chronic hepatitis B infection?
|
|
New "B Heppy" podcast: A Global Perspective on Stigma and Discrimination Against Hepatitis B
|
|
There's a new episode of B Heppy, our popular podcast, on "A Global Perspective on Stigma and Discrimination Against Hepatitis B" for you to check out. In this episode, we chat with Catherine Freeland, associate director of public health research at the Hepatitis B Foundation, on what stigma looks like across the globe and how it impacts the economic, social and emotional well-being of people living with hepatitis B.
The webpage is here. AND, if you'd like to suggest a topic for B Heppy, please send an email to info@hepb.org.
|
|
2023 International HBV Meeting |
|
|
|
This year's HBV International Meeting, which is back in Asia, promises to be even more robust than last year's as the rebounds from the pandemic shutdown continues.
Please take a look at the agenda here.
It's a scientific meeting, but it's important to note that the Community Forum on Sept. 23 is intended for people living with hepatitis B.
We hope to see you there!
|
|
Congressional briefing on hepatitis B |
|
|
|
The Hepatitis B Foundation hosted a congressional briefing on Monday, May 21.
|
|
Topic of discussion was: "Advancing Hepatitis B Elimination Through Universal Hepatitis B Vaccination and Screening". The panel focused on reasons why the hepatitis B virus is still an issue in the United States. Moreover, they explained that the CDC, medical care providers, and community organizations need more funding to increase hepatitis B vaccination and screening.
|
|
Journal article of the month.
|
|
Opportunities to address gaps in early detection and
improve outcomes of liver cancer
Volume 7, Issue 3, June 2023, pkad034, / Published: 5 May 2023
|
|
U.S. deaths from primary liver cancer (hepatocellular carcinoma [HCC]) have continued to increase though there is an increasing range of treatments, including new systemic therapies. Prognosis is strongly associated with tumor stage at diagnosis, but most cases of HCC are diagnosed beyond an early stage. Low survival rates have results from this lack of early detection. The Hepatitis B Foundation hosted a workshop on April 28, 2022, to discuss the most pressing challenges and barriers to early HCC detection and the need to better leverage existing and emerging tools and technologies that could improve HCC screening and early detection. In this article, some participants in the workshop summarize technical, patient-level, provider-level, and system-level challenges and opportunities to improve processes and outcomes across the HCC screening continuum. They highlight promising approaches to HCC risk stratification and screening, including new biomarkers, advanced imaging incorporating artificial intelligence, and algorithms for risk stratification. The authors emphasized that action to improve early detection and reduce HCC mortality is urgently needed, noting concern that many of the challenges we face today are the same or similar to those faced a decade ago and that HCC mortality rates have not meaningfully improved. |
|
July 24-26: Hep B United Summit in Washington, D.C.
July 28: World Hepatitis Day
Sept. 19-23: International HBV Symposium in Kobe, Japan
|
|
Learn more about our research and education programs at www.hepb.org
|
|
The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. Our commitment includes funding focused research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as the primary source of information for patients and their families, the medical and scientific community, and the general public. |
|
|
|
Hepatitis B Foundation I 3805 Old Easton Road Doylestown, PA 18902 I
215-489-4900 I info@hepb.org
|
|
|
|
|
|
|
